©The Author(s) 2025.
World J Gastroenterol. Sep 21, 2025; 31(35): 109687
Published online Sep 21, 2025. doi: 10.3748/wjg.v31.i35.109687
Published online Sep 21, 2025. doi: 10.3748/wjg.v31.i35.109687
Table 3 The efficacy of each parameter in predicting early recurrence
| Characteristic | Combined ECV and CA19-9 | CT-derived ECV | CA19-9 | Tumor grade |
| Cutoff value | 0.45 | 35.37 | 55.00 | Ref. |
| AUC (95%CI) | 0759 (0.653-0.846) | 0.736 (0.628-0.827) | 0.686 (0.575-0.784) | 0.650 (0.538-0.752) |
| Sensitivity | 87.80 | 80.49 | 90.24 | 60.98 |
| Specificity | 69.52 | 59.42 | 45.24 | 69.05 |
| P value | < 0.001 | < 0.001 | 0.002 | 0.005 |
- Citation: Zhang ZW, Liu HT, Zhou ZH, Liao HF, Zhang LL, Li YM, Liang HW. Preoperative risk stratification of early recurrence in resected pancreatic ductal adenocarcinoma: Novel equilibrium-phase-computed tomography biomarker of extracellular volume. World J Gastroenterol 2025; 31(35): 109687
- URL: https://www.wjgnet.com/1007-9327/full/v31/i35/109687.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i35.109687